121 related articles for article (PubMed ID: 29152155)
1. Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.
Mancini M; Soverini S; Gugliotta G; Santucci MA; Rosti G; Cavo M; Martinelli G; Castagnetti F
Oncotarget; 2017 Oct; 8(50):88244-88250. PubMed ID: 29152155
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.
Leo E; Mancini M; Castagnetti F; Gugliotta G; Santucci MA; Martinelli G
J Cell Biochem; 2015 Apr; 116(4):589-97. PubMed ID: 25389112
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
Mancini M; Leo E; Takemaru K; Campi V; Castagnetti F; Soverini S; De Benedittis C; Rosti G; Cavo M; Santucci MA; Martinelli G
PLoS One; 2015; 10(7):e0131074. PubMed ID: 26147002
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.
Leo E; Mancini M; Aluigi M; Luatti S; Castagnetti F; Testoni N; Soverini S; Santucci MA; Martinelli G
PLoS One; 2013; 8(12):e81425. PubMed ID: 24339928
[TBL] [Abstract][Full Text] [Related]
5. Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells.
Mancini M; Leo E; Takemaru K; Campi V; Borsi E; Castagnetti F; Gugliotta G; Santucci MA; Martinelli G
Cell Signal; 2013 Sep; 25(9):1820-7. PubMed ID: 23707389
[TBL] [Abstract][Full Text] [Related]
6. A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib.
Mancini M; Leo E; Campi V; Castagnetti F; Zazzeroni L; Gugliotta G; Santucci MA; Martinelli G
Cell Signal; 2014 Aug; 26(8):1690-7. PubMed ID: 24747551
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
Mancini M; Castagnetti F; Soverini S; Leo E; De Benedittis C; Gugliotta G; Rosti G; Bavaro L; De Santis S; Monaldi C; Martelli M; Santucci MA; Cavo M; Martinelli G
J Cell Biochem; 2017 Nov; 118(11):3968-3975. PubMed ID: 28401599
[TBL] [Abstract][Full Text] [Related]
8. Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.
Mancini M; Petta S; Iacobucci I; Salvestrini V; Barbieri E; Santucci MA
Cell Signal; 2010 Aug; 22(8):1247-53. PubMed ID: 20388540
[TBL] [Abstract][Full Text] [Related]
9. Chibby1 knockdown promotes mesenchymal-to-epithelial transition-like changes.
Fischer V; Wong M; Li FQ; Takemaru KI
Cell Cycle; 2017 Mar; 16(5):448-456. PubMed ID: 28107095
[TBL] [Abstract][Full Text] [Related]
10. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition.
Niu CC; Zhao C; Yang ZD; Zhang XL; Wu WR; Pan J; Zhao C; Li ZQ; Ding W; Yang Z; Si WK
Int J Mol Med; 2013 Feb; 31(2):453-8. PubMed ID: 23233089
[TBL] [Abstract][Full Text] [Related]
12. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
[TBL] [Abstract][Full Text] [Related]
13. MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation.
Colecchia D; Rossi M; Sasdelli F; Sanzone S; Strambi A; Chiariello M
Autophagy; 2015; 11(10):1790-802. PubMed ID: 26291129
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.
Shinohara H; Taniguchi K; Kumazaki M; Yamada N; Ito Y; Otsuki Y; Uno B; Hayakawa F; Minami Y; Naoe T; Akao Y
Cancer Lett; 2015 Apr; 360(1):28-38. PubMed ID: 25644089
[TBL] [Abstract][Full Text] [Related]
17. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
18. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
19. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
20. Role of anti-apoptotic pathways activated by BCR/ABL in the resistance of chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Danisz K; Blasiak J
Acta Biochim Pol; 2013; 60(4):503-14. PubMed ID: 24273759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
